Lazard Asset Management
GHDX

Lazard Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Lazard Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-581
Closed -$39K – 1728
2019
Q3 		$39K Buy
+581
New +$39.9K ﹤0.01% 1012

Lazard Asset Management's GHDX Position: Q4 2019 in Review

Lazard Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 581 shares — an estimated $39K sold.

Lazard Asset Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $39K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Lazard Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Lazard Asset Management sold 581 Genomic Health, Inc. shares in Q4 2019, an estimated $39K.
  • Lazard Asset Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
  • Lazard Asset Management's Genomic Health, Inc. position peaked at $39K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.